The 
basics 
of 
clinical 
trials 
10 
October 
2014
What 
is 
a 
clinical 
trial? 
A 
clinical 
trial 
is 
a 
research 
study, 
relying 
upon 
human 
volunteers, 
that 
allows 
scien7sts 
to 
inves7gate 
and 
answer 
specific 
medical 
ques7ons 
Yesterday’s 
research 
leads 
to 
today’s 
treatments 
and 
tomorrow’s 
cures.
What 
do 
trials 
accomplish? 
Trials 
test 
new 
ways 
to… 
¢ Prevent 
breast 
cancer 
¢ Diagnose 
breast 
cancer 
¢ Treat 
or 
cure 
breast 
cancer 
¢ Improve 
quality 
of 
life 
during 
and 
aAer 
treatment
What 
do 
clinical 
trial 
“phases” 
mean? 
Each 
clinical 
trial 
is 
classified 
into 
one 
of 
4 
phases, 
depending 
on 
what 
it 
is 
tesEng: 
• Ensuring 
safety 
• IdenEfying 
side 
effects 
• Confirming 
dosage 
• Further 
evaluaEng 
safety 
• TesEng 
effecEveness 
of 
a 
treatment 
• Confirming 
effecEveness 
• Comparing 
to 
current 
standard 
treatments 
• Monitoring 
side 
effects 
• Monitoring 
long 
term 
effects 
• IdenEfying 
new 
uses 
of 
the 
treatment 
Phase 
1 
Phase 
2 
Phase 
3 
Phase 
4
The 
doctor 
(Principal 
Inves7gator, 
or 
PI) 
in 
charge 
of 
the 
trial 
is 
responsible 
for 
a 
trial 
protocol 
which 
includes: 
¢ Why 
the 
trial 
is 
required 
¢ Who 
is 
eligible 
to 
par7cipate 
¢ How 
many 
pa7ents 
are 
needed 
¢ What 
drugs, 
if 
any, 
will 
be 
given; 
how 
much 
and 
when 
¢ What 
tests 
will 
be 
done, 
and 
when 
¢ What 
pa7ent 
informa7on 
will 
be 
collected 
How 
is 
a 
trial 
defined?
What 
happens 
next? 
¢ Poten7ally 
eligible 
pa7ents 
are 
iden7fied 
¢ They 
receive 
detailed 
informa7on 
from 
their 
doctors 
about 
the 
trial 
¢ They 
are 
asked 
to 
sign 
an 
“Informed 
Consent” 
form 
to 
show 
that 
they 
have 
been 
properly 
informed 
about 
the 
study
How 
are 
paEents 
recruited? 
¢ Pa7ents 
are 
chosen 
based 
on 
factors 
including 
age, 
gender, 
type 
and 
stage 
of 
breast 
cancer, 
treatment 
history 
and 
other 
medical 
condi7ons 
¢ Some7mes 
pa7ents 
must 
be 
recruited 
from 
many 
countries 
in 
order 
to 
ensure 
that 
enough 
people 
will 
par7cipate 
so 
that 
the 
study 
will 
have 
sta7s7cal 
validity
Do 
all 
paEents 
receive 
the 
same 
treatment? 
¢ All 
Phase 
3 
trials 
(and 
some 
in 
Phase 
2) 
use 
randomiza7on 
by 
computer 
to 
put 
pa7ents 
into 
groups 
receiving 
different 
treatments 
¢ One 
group 
(the 
control 
group) 
receives 
the 
current 
standard 
of 
care 
¢ One 
or 
more 
groups 
receive 
the 
therapy 
being 
tested, 
some7mes 
in 
different 
combina7ons
How 
long 
does 
a 
trial 
last? 
¢ Researchers 
monitor 
pa7ents 
for 
weeks, 
months 
or 
years, 
depending 
on 
the 
trial 
protocol 
¢ Some 
trials 
follow 
pa7ents 
for 
more 
than 
10 
years, 
for 
example 
to 
track 
long-­‐term 
pa7ent 
safety
The 
typical 
life 
of 
a 
trial 
Recruitment 
Study 
Interim 
Results 
Follow-­‐up 
Review 
Protocol 
Final 
Results 
6 
months 
– 
10 
years 
6 
months 
– 
5 
years 
6 
months 
– 
10 
years 
EnEre 
duraEon 
of 
trial
What 
are 
the 
risks 
and 
benefits 
of 
parEcipaEng 
in 
a 
trial? 
Benefits 
include: 
¢ Access 
to 
promising 
new 
treatments 
not 
available 
outside 
the 
trial 
¢ More 
individualized 
medical 
aXen7on, 
such 
as 
addi7onal 
tests 
and 
check-­‐ups 
¢ Contribu7on 
to 
improved 
treatments 
for 
future 
pa7ents 
Risks 
include: 
¢ Experimental 
treatment 
could 
prove 
ineffec7ve 
¢ Treatment 
side 
effects 
¢ Addi7onal 
7me 
required 
at 
the 
hospital 
for 
tests 
and 
check-­‐ups
Why 
support 
clinical 
trials? 
¢ Clinical 
trials 
provide 
us 
with 
the 
knowledge 
we 
need 
to 
treat 
breast 
cancer 
beXer 
¢ Now 
is 
the 
7me 
for 
scien7sts 
to 
make 
significant 
progress 
in 
answering 
ques7ons 
about 
how 
to 
treat 
and 
cure 
breast 
cancer
Support 
trials 
and 
enable 
progress 
towards 
a 
cure 
for 
breast 
cancer 
Today’s 
donaEons 
support 
tomorrow’s 
trials 
and 
future 
cures.
Sources 
For 
more 
informaEon: 
www.bigagainstbreastcancer.org 
www.breastcancertrials.org 
www.breastcancer.org/treatment/clinical_trials 
www.cancer.gov/clinicaltrials 
www.cancer.org/treatment/treatmentsandsideeffects/clinicaltrials/ 
www.cancerresearchuk.org/about-­‐cancer/trials/ 
www.clinicaltrials.gov

The basics of clinical trials

  • 1.
    The basics of clinical trials 10 October 2014
  • 2.
    What is a clinical trial? A clinical trial is a research study, relying upon human volunteers, that allows scien7sts to inves7gate and answer specific medical ques7ons Yesterday’s research leads to today’s treatments and tomorrow’s cures.
  • 3.
    What do trials accomplish? Trials test new ways to… ¢ Prevent breast cancer ¢ Diagnose breast cancer ¢ Treat or cure breast cancer ¢ Improve quality of life during and aAer treatment
  • 4.
    What do clinical trial “phases” mean? Each clinical trial is classified into one of 4 phases, depending on what it is tesEng: • Ensuring safety • IdenEfying side effects • Confirming dosage • Further evaluaEng safety • TesEng effecEveness of a treatment • Confirming effecEveness • Comparing to current standard treatments • Monitoring side effects • Monitoring long term effects • IdenEfying new uses of the treatment Phase 1 Phase 2 Phase 3 Phase 4
  • 5.
    The doctor (Principal Inves7gator, or PI) in charge of the trial is responsible for a trial protocol which includes: ¢ Why the trial is required ¢ Who is eligible to par7cipate ¢ How many pa7ents are needed ¢ What drugs, if any, will be given; how much and when ¢ What tests will be done, and when ¢ What pa7ent informa7on will be collected How is a trial defined?
  • 6.
    What happens next? ¢ Poten7ally eligible pa7ents are iden7fied ¢ They receive detailed informa7on from their doctors about the trial ¢ They are asked to sign an “Informed Consent” form to show that they have been properly informed about the study
  • 7.
    How are paEents recruited? ¢ Pa7ents are chosen based on factors including age, gender, type and stage of breast cancer, treatment history and other medical condi7ons ¢ Some7mes pa7ents must be recruited from many countries in order to ensure that enough people will par7cipate so that the study will have sta7s7cal validity
  • 8.
    Do all paEents receive the same treatment? ¢ All Phase 3 trials (and some in Phase 2) use randomiza7on by computer to put pa7ents into groups receiving different treatments ¢ One group (the control group) receives the current standard of care ¢ One or more groups receive the therapy being tested, some7mes in different combina7ons
  • 9.
    How long does a trial last? ¢ Researchers monitor pa7ents for weeks, months or years, depending on the trial protocol ¢ Some trials follow pa7ents for more than 10 years, for example to track long-­‐term pa7ent safety
  • 10.
    The typical life of a trial Recruitment Study Interim Results Follow-­‐up Review Protocol Final Results 6 months – 10 years 6 months – 5 years 6 months – 10 years EnEre duraEon of trial
  • 11.
    What are the risks and benefits of parEcipaEng in a trial? Benefits include: ¢ Access to promising new treatments not available outside the trial ¢ More individualized medical aXen7on, such as addi7onal tests and check-­‐ups ¢ Contribu7on to improved treatments for future pa7ents Risks include: ¢ Experimental treatment could prove ineffec7ve ¢ Treatment side effects ¢ Addi7onal 7me required at the hospital for tests and check-­‐ups
  • 12.
    Why support clinical trials? ¢ Clinical trials provide us with the knowledge we need to treat breast cancer beXer ¢ Now is the 7me for scien7sts to make significant progress in answering ques7ons about how to treat and cure breast cancer
  • 13.
    Support trials and enable progress towards a cure for breast cancer Today’s donaEons support tomorrow’s trials and future cures.
  • 14.
    Sources For more informaEon: www.bigagainstbreastcancer.org www.breastcancertrials.org www.breastcancer.org/treatment/clinical_trials www.cancer.gov/clinicaltrials www.cancer.org/treatment/treatmentsandsideeffects/clinicaltrials/ www.cancerresearchuk.org/about-­‐cancer/trials/ www.clinicaltrials.gov